These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28708471)

  • 1. Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.
    Fournier A; Mesrine S; Gelot A; Fagherazzi G; Baglietto L; Clavel-Chapelon F; Boutron-Ruault MC; Chabbert-Buffet N
    J Clin Oncol; 2017 Oct; 35(28):3230-3239. PubMed ID: 28708471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.
    de Lauzon-Guillain B; Fournier A; Fabre A; Simon N; Mesrine S; Boutron-Ruault MC; Balkau B; Clavel-Chapelon F
    Diabetologia; 2009 Oct; 52(10):2092-100. PubMed ID: 19629429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study.
    Touillaud M; Gelot A; Mesrine S; Bennetau-Pelissero C; Clavel-Chapelon F; Arveux P; Bonnet F; Gunter M; Boutron-Ruault MC; Fournier A
    Am J Clin Nutr; 2019 Mar; 109(3):597-605. PubMed ID: 30831601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Am J Clin Nutr; 2016 Jul; 104(1):228-34. PubMed ID: 27194303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid consumption and incident type 2 diabetes: an 18-year follow-up in the female E3N (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale) prospective cohort study.
    Dow C; Mangin M; Balkau B; Affret A; Boutron-Ruault MC; Clavel-Chapelon F; Bonnet F; Fagherazzi G
    Br J Nutr; 2016 Nov; 116(10):1807-1815. PubMed ID: 27842617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study.
    Salliot C; Nguyen Y; Gusto G; Gelot A; Gambaretti J; Mariette X; Boutron-Ruault MC; Seror R
    Rheumatology (Oxford); 2021 Oct; 60(10):4790-4800. PubMed ID: 33547777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth weight, body silhouette over the life course, and incident diabetes in 91,453 middle-aged women from the French Etude Epidemiologique de Femmes de la Mutuelle Generale de l'Education Nationale (E3N) Cohort.
    de Lauzon-Guillain B; Balkau B; Charles MA; Romieu I; Boutron-Ruault MC; Clavel-Chapelon F
    Diabetes Care; 2010 Feb; 33(2):298-303. PubMed ID: 19918011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palaeolithic diet score and risk of breast cancer among postmenopausal women overall and by hormone receptor and histologic subtypes.
    Shah S; Mahamat-Saleh Y; Hajji-Louati M; Correia E; Oulhote Y; Boutron-Ruault MC; Laouali N
    Eur J Clin Nutr; 2023 May; 77(5):596-602. PubMed ID: 36726032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohort.
    Danjou AMN; Coudon T; Praud D; Lévêque E; Faure E; Salizzoni P; Le Romancer M; Severi G; Mancini FR; Leffondré K; Dossus L; Fervers B
    Environ Int; 2019 Mar; 124():236-248. PubMed ID: 30658268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent recreational physical activity and breast cancer risk in postmenopausal women in the E3N cohort.
    Fournier A; Dos Santos G; Guillas G; Bertsch J; Duclos M; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1893-902. PubMed ID: 25114017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term adherence to healthful and unhealthful plant-based diets and breast cancer risk overall and by hormone receptor and histologic subtypes among postmenopausal females.
    Shah S; Mahamat-Saleh Y; Ait-Hadad W; Koemel NA; Varraso R; Boutron-Ruault MC; Laouali N
    Am J Clin Nutr; 2023 Mar; 117(3):467-476. PubMed ID: 36872016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
    Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohort Profile: The French E3N Cohort Study.
    Clavel-Chapelon F;
    Int J Epidemiol; 2015 Jun; 44(3):801-9. PubMed ID: 25212479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronutrient dietary patterns associated with type 2 diabetes mellitus among women of the E3N-EPIC (Etude Epidémiologique auprès de femmes de l'Education Nationale) cohort study.
    Mancini FR; Dow C; Affret A; Rajaobelina K; Dartois L; Balkau B; Bonnet F; Boutron-Ruault MC; Fagherazzi G
    J Diabetes; 2018 Aug; 10(8):665-674. PubMed ID: 29457678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
    Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
    Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort.
    Lafourcade A; His M; Baglietto L; Boutron-Ruault MC; Dossus L; Rondeau V
    BMC Cancer; 2018 Feb; 18(1):171. PubMed ID: 29426294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
    Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
    Dumeaux V; Fournier A; Lund E; Clavel-Chapelon F
    Cancer Causes Control; 2005 Jun; 16(5):537-44. PubMed ID: 15986108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.